Gene deletion chemoselectivity: Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, and the α- and β-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1083-1090

  Chen, Zhi Hao ^a   Zhang, Hongyang ^a   Savarese, Todd M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; PHOSPHORYLASE;

ARTICLE; CARCINOMA CELL; CHROMOSOME 9P; DRUG SELECTIVITY; GENE CLUSTER; GENE DELETION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PANCREAS CANCER; POLYAMINE METABOLISM; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; BASE SEQUENCE; CARCINOMA; DRUG RESISTANCE; GENE DELETION; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; METHOTREXATE; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PURINE-NUCLEOSIDE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0030023025     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Weinberg, R. A Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
2. Kamb, A Gruts, N A., Weaver-Fledhaus, J , Liu, Q., Harshman, K., Tavtigian, S. V , Stockert, E., Day, R. S. III, Johnson, B. E., and Skolnick, M. H A cell cycle regulator potentially involved in the genesis of many tumor types Science (Washington DC), 264: 436-440, 1994.
3. Serrano, M., Hannon, G. J , and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366 704-707, 1993.
4. INK4B is a potential effector of TGF-β-induced cell cycle arrest Nature (Lond.), 371, 257-261, 1994.
5. 1 phase progression cyclins on cue. Cell, 79: 551-555, 1994.
6. Nobori, T., Mirua, K. Wu, D J., Lois, A , Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature (Lond), 368: 753-756, 1994
7. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M , Tanaka, T., Mitani, K , Yazaki, Y., and Hirai, H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias Blood, 84: 2431-2435, 1994
8. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038-4044, 1994.
9. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res., 55: 1436-1440, 1995.
10. Hussussian, C J , Struewing, J. P., Goldstein, A. M., Higgins, P A. T , Ally, D S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
11. Reed, J. A., Loganzo, F., Jr , Shea, C. R., Walker, G. J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M. J., Haluska, F. G., Fountain, J W. F., and Albino, A. P. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55: 2713-2718, 1995.
12. Jen, J., Harper, J. W., Bigner, S., Bigner, D. D. Papadopoulos, N., Markowirz, S., Willson, J. K. V , Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358, 1994.
13. INK4 expression in primary lung cancers and cell lines. Cancer Res., 55: 505-509, 1995.
14. Xiao, S , Li, D, Corson, J. M., Vijg, J., and Fletcher, J. A. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res., 55: 2968-2971, 1995.
15. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T., and Takahashi, T. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in nonsmall cell lung cancers. Cancer Res., 55, 514-517, 1995.
16. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S , and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54: 3396-3397, 1994.
17. Cheng, J. Q , Jhanwar, S. C., Klein, W. M., Bell, D. W., Lee, W-C., Altomare, D. A., Nobori, T , Olopade, O. I., Buckler, A J., and Testa, J R. p16 alterations and deletion mapping of 9p21-p22 in malignant mesotheliomas. Cancer Res., 54 5547-5551, 1994.
18. Caldas, C., Hahn, S. A., daCosta, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomas. Nat. Genet , 8: 27-32, 1994
19. Olopade, O. I., Pomykala, H M., Hagos, F., Sveen, L W , Espinosa, R. III, Dreyling, M. H , Gursky, S., Stadler, W. M., LeBeau, M. M., and Bohlander, S. K Construction of a 2.8 megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc. Natl. Acad. Sci. USA, 92: 6489-6493, 1995.
20. Diaz, M O., Ziemin, S., LeBeau, M. M., Pitha, P. Smith, S D , Chilcote, R. R., and Rowley, J. D. Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc Natl. Acad. Sci. USA, 85: 5259-5263, 1988.
21. Zhang, H. Y., Chen, Z. H , and Savarese, T. M. Codeletion of the genes for p16INK4 methylthioadenosine phosphorylase, interferon-α1, interferon-β1, and other 9p21 markers in human malignant cell lines. Cancer. Genet. Cytogenet., in press, 1996
22. Schlenk, F. Methylthioadenosine. In: A. Meister (ed.). Advances in Enzymology and Related Areas in Molecular Biology, pp. 195-265. New York John Wiley & Sons, 1983.
23. Savarese, T M., Crabtree, G. W., and Parks, R E., Jr. Methylthioadenosine phosphoryldse-I. Substrate activity of 5′-deoxyadenosine with the enzyme from Sarcoma 180 cells Biochem. Pharmacol., 30, 189-199, 1981.
24. Kamatani, N. and Carson, D. A Dependence of adenine production upon polyamine synthesis in cultured human lymphoblasts. Biochim. Biophys. Acta, 675: 344-350, 1981.
25. Williams-Ashman, H. G., Scidenfeld, J., and Galletti, P. Trends in the biochemical pharmacology of 5′-deoxy-5′-methylthioadenosine Biochem. Pharmacol, 31: 277-288, 1982.
26. Kamatani, N., and Carson, D A. Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemia cell lines. Cancer Res , 40: 4178-4182, 1980
27. Allegra, C. J., Hoang, K , Yeh, G. C., Drake, J. C., and Baram, J Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate J Biol Chem., 262: 13520-13526, 1987.
28. Kamatani, N , Nelson-Rees, W. A., and Carson, D. A. Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proc Natl. Acad Sci. USA, 78, 1219-1223, 1981.
29. Nobori, T , Karras, J G., Ragione, F. D., Waltz, T. A., Chen, P. P., and Carson, D. A. Absence of methylthioadenosine phosphorylase in human gliomas. Cancer Res., 51: 3193-3197, 1991.
30. Nobori, T., Szinai, I., Amox, D., Parker, B., Olopade, O. I., Buchhagen, D. L., and Carson, D. A. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res., 53: 1098-1101, 1993.
31. Gresser, I. Antitumor effects of interferon. Acta Oncol., 28: 347-353, 1989
32. Stiles, G. L., Caron, M. C , and Lefkowitz, R. J. β-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol. Rev., 64, 661-743, 1984.
33. Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., Lahti, J., Kidd, V. J , Housman, D. E., and Dracopoli, N. C. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci. USA, 98: 10557-10561, 1992
34. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
35. Kwiatkowski, D. J., Armour, J., Bale, A. E., Fountain, J. W., Goudie, D., Haines, J. L., Knowles, M. A., Pilz, A., Slaugenhaupt, S , and Povey, S. Report on the second international workshop on human chromosome 9. Cytogenet. Cell Genet., 64: 94-103, 1993.
36. Murty, V. V V. S., Bouchard, B., Mathew, S., Vijayasaradhi, S., and Houghton, A. N. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridization Genomics, 3, 227-229, 1992.
37. Allegra, C. J , Drake, J C , Jolivet, J., and Chabner, B. A. Inhibition of phosphoribosyl-aminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates Proc. Natl Acad. Sci. USA, 82: 4881-4885, 1985.
38. Allegra, C J., Drake, J C., Jolivet, J., and Chabner, B. A. Inhibition of the folate-dependent enzymes of the de novo purine synthesis and folate interconverting enzymes by methotrexate polyglutamates (MTX-PGs). Proc. Am. Assoc. Cancer Res , 25: 6, 1984.
39. Jackson, R. C., and Grindey, G. B. The biochemical basis for methotrexate cytotoxictty. In: F. M. Sirotnak, J. J. Burchall, and W. D. Ensmigner (eds.) Folate Antagonists as Therapeutic Agents, Vol 1, pp 289-315. New York: Academic Press, Inc., 1984.
40. Chu, S-H., Ho, L., Chu, E., Savarese, T., Chen, Z H., and Chu, M Y 5′-Halogenated formycins as inhibitors of 5′-deoxy-5′-methylthioadenosine phosphorylase: protection of cells against the growth-inhibitory activity of 5′-halogenated adenosines. Nucleosides & Nucleotides, 5: 185-200, 1986.
41. Gordon, R. B., Blackwell, K., and Emmerson, B. T. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity. Biochim. Biophys. Acta, 927, 1-7, 1987.
42. Trackman, P. C., and Abeles, R. H Methionine synthesis from 5′-S-methylthioadenosine. J. Biol. Chem., 218: 6717-6720, 1983.
43. Beardsley, G. P , Moroson, B. A., Taylor, E. C., and Moran, R. G. A new fotate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate, is a potent inhibitor of de novo purine synthesis. J Biol Chem., 264: 328-333, 1989.
44. Ray, M. S., Muggia, F M , Leichman, C. G., Grunberg, S. M., Nelson, R. L., Dyke, R. W , and Moran, R. G. Phase I study of(6R)-5,10-dideazatetrahydrofolate: a folate anumetabolite inhibitory to de novo purine synthesis. J Natl. Cancer Inst., 85: 1154-1159, 1993.
45. Toohey, J. I Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells. Biochem. Biophys. Res. Commun., 83: 27-35, 1978.
46. Riscoe, M. K., and Ferro, A. J. 5-Methylthioribose: its effects and function in mammalian cells J Biol Chem , 259: 5465-5471, 1984.
47. Savarese, T. M., Cannistra, A. J , Parks, R. E., Jr., Secrist, J. A. III, Shortnacy, A. T., and Montgomery, J A. 5′-Deoxy-5′-methylthioadenosine phosphorylase-IV. Biological activity of 2-fluoroadenine-substituted 5′-deoxy-5′-methylthioadenosine analogs Biochem. Pharmacol., 36 1881-1983, 1987.
48. Miyakoshi, J., Dobler, K. D., Allalunis-Turner, J, McKean, J D. S., Petruk, K , Allen, P. B. R., Aronyk, K. N., Weir, B., Huyser-Wierenga, D., Fulton, D., Urtasun, R. C , and Day, R S. III Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res , 50, 278-283, 1990.
49. Schein, P S , Lavin, P. T., Moertel, C. G., Frytak, S., Hahn, R. G., O'Connell, M. J., Reitemeier, R. J. Rubin, J., Schutt, A J., Weiland, L. H., Kalser, M., Barkin, J., Lessner, H , Mann-Kaplan, R., Redhammer, D., Silverman, M , Troner, M , Douglass, H O., Jr., Milliron, S., Lokich, J., Brooks, J., Chaffe, J., Like, A., Zamcheck, N , Ramming, K , Bateman, J., Spiro, H., Livstone, E , and Knowlton, A. Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group report Cancer (Phila), 42: 19-22, 1978.